GWW vs PVLA · P/E 27, rev $9.76B vs $1.64B cap
WW Grainger Inc (GWW) versus Palvella Therapeutics, Inc (PVLA) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Palvella Therapeutics, Inc (PVLA) is a biotechnology company listed on NASDAQ.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
PVLA does not have a complete income-statement cache yet.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. PVLA currently screens at market cap $1.64B.
Not investment advice. Open the GWW and PVLA stock pages for the full models.
Not investment advice.